VMP 42276611000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Paroxetine 30mg tablets
BNF code 0403030P0AAABAB
Virtual Therapeutic Moiety Paroxetine
Date identifier became valid 22 Sep 2023
Previous product identifier 321966008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Paroxetine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372595009
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Paroxetine 30mg tablets (A A H Pharmaceuticals Ltd)
Paroxetine 30mg tablets (Accord-UK Ltd)
Paroxetine 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Paroxetine 30mg tablets (Almus Pharmaceuticals Ltd)
Paroxetine 30mg tablets (Crescent Pharma Ltd)
Paroxetine 30mg tablets (Genesis Pharmaceuticals Ltd)
Paroxetine 30mg tablets (Medihealth (Northern) Ltd)
Paroxetine 30mg tablets (Medreich Plc)
Paroxetine 30mg tablets (Milpharm Ltd)
Paroxetine 30mg tablets (Phoenix Healthcare Distribution Ltd)
Paroxetine 30mg tablets (Rudipharm Ltd)
Paroxetine 30mg tablets (Sandoz Ltd)
Paroxetine 30mg tablets (Sigma Pharmaceuticals Plc)
Seroxat 30mg tablets (GlaxoSmithKline UK Ltd)
Seroxat 30mg tablets (Lexon (UK) Ltd)
Virtual Medicinal Product Packs
Paroxetine 30mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.

Feedback